Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L01AX03	TEMOZOLOMIDE GP PHARM	G	Temozolomide - 250mg	250mg	Capsule, hard	12,058,004 L.L
L01AX03	TEMODAL	B	Temozolomide - 20mg	20mg	Capsule	1,612,611 L.L
L01AX03	TEMOZOLOMIDE ACCORD	G	Temozolomide - 20mg	20mg	Capsule, hard	1,153,017 L.L
L01AX03	TEMOZOLOMIDE GP PHARM	G	Temozolomide - 20mg	20mg	Capsule, hard	920,532 L.L
L01AX03	TEGOZOL	G	Temozolomide - 20mg	100mg	Capsule	967,567 L.L
L01AX03	TEMODAL	B	Temozolomide - 100mg	100mg	Capsule	7,731,224 L.L
L01AX03	TEGOZOL	G	Temozolomide - 100mg	100mg	Capsule	5,005,813 L.L
L01AX03	TEMOZOLOMIDE ACCORD	G	Temozolomide - 100mg	100mg	Capsule, hard	5,590,385 L.L
L01AX03	TEMOZOLOMIDE GP PHARM	G	Temozolomide - 100mg	100mg	Capsule, hard	4,511,279 L.L
C09DA07	TELMICARD 80 PLUS	G	Telmisartan - 80mg, Hydrochlorothiazide - 12.5mg		Tablet	954,768 L.L
C09DB04	TWYNSTA	B	Telmisartan - 80mg, Amlodipine - 5mg		Tablet	991,756 L.L
C09DB04	TWINCARD 80/5	G	Telmisartan - 80mg, Amlodipine - 5mg		Tablet	1,372,511 L.L
C09DB04	TWYNSTA	B	Telmisartan - 80mg, Amlodipine - 10mg		Tablet	991,756 L.L
C09DB04	TWINCARD 80/10	G	Telmisartan - 80mg, Amlodipine - 10mg		Tablet	1,460,309 L.L
C09CA07	TELMICARD 80	G	Telmisartan - 80mg	80mg	Tablet	865,179 L.L
C09CA07	TOLURA	G	Telmisartan - 80mg	80mg	Tablet	698,798 L.L
C09CA07	TELMICARD 40	G	Telmisartan - 40mg	40mg	Tablet	659,123 L.L
C09CA07	TOLURA	G	Telmisartan - 40mg	40mg	Tablet	532,162 L.L
J01XA02	TARGOCID	B	Teicoplanin - 400mg	400mg	Injectable lyophilised powder for solution+diluent	1,331,748 L.L
J01XA02	TEICO MEDIS 400	G	Teicoplanin - 400mg	400mg	Injectable lyophilised powder	1,157,048 L.L
J01XA02	TARGOCID	B	Teicoplanin - 200mg	200mg	Injectable lyophilised powder for solution+diluent	714,924 L.L
J01XA02	TEICO MEDIS 200	G	Teicoplanin - 200mg	200mg	Injectable lyophilised powder	428,686 L.L
L01FX24	TECVAYLI	BioTech	Teclistamab - 90mg/ml	90mg/ml	Injectable solution	483,720,518 L.L
L01FX24	TECVAYLI	BioTech	Teclistamab - 90mg/ml	90mg/ml	Injectable solution	L.L
L01FX24	TECVAYLI	BioTech	Teclistamab - 10mg/ml	10mg/ml	Injectable solution	95,166,436 L.L
G04CA02	TALUSIN	G	Tamsulosin HCl - 0.4mg	0.4mg	Capsule, modified release	683,440 L.L
G04CA02	TAMSU GENERICON RETARD	G	Tamsulosin - 0.4mg	0.4mg	Capsule, hard, modified release	615,480 L.L
L02BA01	TAMOXIFEN SANDOZ	G	Tamoxifen (citrate) - 20mg	20mg	Tablet, film coated	497,222 L.L
L02BA01	TAMOXIFENE BIOGARAN	G	Tamoxifen (citrate) - 20mg	20mg	Tablet	858,715 L.L
L02BA01	TAMOXIFENE BIOGARAN	G	Tamoxifen (citrate) - 10mg	10mg	Tablet	415,247 L.L

...